Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microbiome—Microbial Metabolome—Cancer Cell Interactions in Breast Cancer—Familiar, but Unexplored
Edit Mikó, Tündé Kovàcs, Éva Sebő, et al.
Cells (2019) Vol. 8, Iss. 4, pp. 293-293
Open Access | Times Cited: 177

Showing 1-25 of 177 citing articles:

Gut Bacteroides species in health and disease
Hassan Zafar, Milton H. Saier
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 739
Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome
Ziying Zhang, Haosheng Tang, Peng Chen, et al.
Signal Transduction and Targeted Therapy (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 207
The Microbiome–Estrogen Connection and Breast Cancer Risk
Sheetal Parida, Dipali Sharma
Cells (2019) Vol. 8, Iss. 12, pp. 1642-1642
Open Access | Times Cited: 181
Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer
Alice Tzeng, Naseer Sangwan, Margaret Jia, et al.
Genome Medicine (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 172
The role of bile acids in carcinogenesis
Tadeja Režen, Damjana Rozman, Tündé Kovàcs, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 5
Open Access | Times Cited: 163
Targeting the gut‐skin axis—Probiotics as new tools for skin disorder management?
Magdolna Szántó, Anikó Dózsa, Dóra Antal, et al.
Experimental Dermatology (2019) Vol. 28, Iss. 11, pp. 1210-1218
Open Access | Times Cited: 146
Breast and Gut Microbiota Action Mechanisms in Breast Cancer Pathogenesis and Treatment
Aurora Laborda-Illanes, Lidia Sánchez‐Alcoholado, María Emilia Domínguez-Recio, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2465-2465
Open Access | Times Cited: 145
The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling
Adrienn Sipos, Gyula Ujlaki, Edit Mikó, et al.
Molecular Medicine (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 101
Microbiome in cancer: Role in carcinogenesis and impact in therapeutic strategies
Md. Mominur Rahman, Md. Rezaul Islam, Sheikh Shohag, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112898-112898
Open Access | Times Cited: 80
Metabolic reprogramming in triple-negative breast cancer
Zhanyu Wang, Qianjin Jiang, Chenfang Dong
Cancer Biology and Medicine (2020) Vol. 17, Iss. 1, pp. 44-59
Open Access | Times Cited: 133
Microbiota-Derived Metabolites in Tumor Progression and Metastasis
Tania Rossi, Daniele Vergara, Francesca Fanini, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5786-5786
Open Access | Times Cited: 112
Indolepropionic Acid, a Metabolite of the Microbiome, Has Cytostatic Properties in Breast Cancer by Activating AHR and PXR Receptors and Inducing Oxidative Stress
Zsanett Sári, Edit Mikó, Tündé Kovàcs, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2411-2411
Open Access | Times Cited: 99
Human Microbiota and Breast Cancer—Is There Any Relevant Link?—A Literature Review and New Horizons Toward Personalised Medicine
Diogo Alpuim Costa, José Guilherme Nobre, Marta Vaz Batista, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 98
Lithocholic Acid, a Metabolite of the Microbiome, Increases Oxidative Stress in Breast Cancer
Patrik Kovács, Tamás Csonka, Tündé Kovàcs, et al.
Cancers (2019) Vol. 11, Iss. 9, pp. 1255-1255
Open Access | Times Cited: 92
The Microbiome as a Component of the Tumor Microenvironment
Tündé Kovàcs, Edit Mikó, Gyula Ujlaki, et al.
Advances in experimental medicine and biology (2020), pp. 137-153
Closed Access | Times Cited: 91
Plasma metabolites as possible biomarkers for diagnosis of breast cancer
Ji Won Park, Yumi Shin, Tae Hyun Kim, et al.
PLoS ONE (2019) Vol. 14, Iss. 12, pp. e0225129-e0225129
Open Access | Times Cited: 90
The Metabolic Fates of Pyruvate in Normal and Neoplastic Cells
Edward V. Prochownik, Huabo Wang
Cells (2021) Vol. 10, Iss. 4, pp. 762-762
Open Access | Times Cited: 84
Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism
Katarína Smolková, Edit Mikó, Tündé Kovàcs, et al.
Antioxidants and Redox Signaling (2020) Vol. 33, Iss. 13, pp. 966-997
Open Access | Times Cited: 70
Faecal Microbiota Composition Varies between Patients with Breast Cancer and Healthy Women: A Comparative Case-Control Study
Christine Bobin‐Dubigeon, Huyen Trang Luu, Sébastien Leuillet, et al.
Nutrients (2021) Vol. 13, Iss. 8, pp. 2705-2705
Open Access | Times Cited: 66
Role of Gut Microbiota Dysbiosis in Breast Cancer and Novel Approaches in Prevention, Diagnosis, and Treatment
Sheila W Ruo, Tasnim Alkayyali, Myat Thu Thu Win, et al.
Cureus (2021)
Open Access | Times Cited: 61
The Gut Microbiome and Female Health
Ruqaiyyah Siddiqui, Zinb Makhlouf, Ahmad M. Alharbi, et al.
Biology (2022) Vol. 11, Iss. 11, pp. 1683-1683
Open Access | Times Cited: 42
Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer?
Indranil Chattopadhyay, Rohit Gundamaraju, Niraj Kumar Jha, et al.
Disease Markers (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 39
The gut microbiota in breast cancer development and treatment: The good, the bad, and the useful!
Deeptashree Nandi, Sheetal Parida, Dipali Sharma
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 36
Microbiota of the gastrointestinal tract: Friend or foe?
M. A. Senchukova
World Journal of Gastroenterology (2023) Vol. 29, Iss. 1, pp. 19-42
Open Access | Times Cited: 30
Breast cancer patients from the Midwest region of the United States have reduced levels of short-chain fatty acid-producing gut bacteria
Rachel L. Shrode, Jessica Knobbe, Nicole Cady, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top